Kanker Payudara

AI Unlocks New Potential in Early Breast Cancer Detection: UCLA Study Points to Significant Reduction in Interval Cancers

• Medical Research and Clinical Trials

AI Unlocks New Potential in Early Breast Cancer Detection: UCLA Study Points to Significant Reduction in Interval Cancers

Lina Hope July 3, 2026

Los Angeles, CA – A groundbreaking new study spearheaded by investigators at the UCLA Health Jonsson Comprehensive...

Read More Read more about AI Unlocks New Potential in Early Breast Cancer Detection: UCLA Study Points to Significant Reduction in Interval Cancers

Breakthrough in At-Home Diagnostics: Visby Medical Secures FDA Clearance for Rapid Flu and Covid-19 PCR Test

• Treatment Innovations

Breakthrough in At-Home Diagnostics: Visby Medical Secures FDA Clearance for Rapid Flu and Covid-19 PCR Test

Asro July 3, 2026

In a significant leap forward for consumer health technology, California-based diagnostics innovator Visby Medical has received US...

Read More Read more about Breakthrough in At-Home Diagnostics: Visby Medical Secures FDA Clearance for Rapid Flu and Covid-19 PCR Test

Strengthening the Frontline: WHO Grants First Emergency Use Listing for Bundibugyo Virus Diagnostic Test

• Global Breast Cancer Awareness

Strengthening the Frontline: WHO Grants First Emergency Use Listing for Bundibugyo Virus Diagnostic Test

Laily UPN July 3, 2026

GENEVA/KINSHASA — In a landmark development for global health security, the World Health Organization (WHO) has officially...

Read More Read more about Strengthening the Frontline: WHO Grants First Emergency Use Listing for Bundibugyo Virus Diagnostic Test

Global Health Agencies Launch Crucial Trials and Diagnostics Amidst Growing Bundibugyo Virus Threat

• Medical Research and Clinical Trials

Global Health Agencies Launch Crucial Trials and Diagnostics Amidst Growing Bundibugyo Virus Threat

Reynand Wu July 3, 2026

Geneva, Switzerland – [Insert Date] – In a concerted effort to combat the escalating threat of the...

Read More Read more about Global Health Agencies Launch Crucial Trials and Diagnostics Amidst Growing Bundibugyo Virus Threat

The Great Coding Divide: Navigating the $76 Billion Debate in Medicare Advantage

• Breast Cancer Legislation and Policy

The Great Coding Divide: Navigating the $76 Billion Debate in Medicare Advantage

Pevita Pearce July 3, 2026

In the landscape of American healthcare, the Medicare Advantage (MA) program has become a dominant force, covering...

Read More Read more about The Great Coding Divide: Navigating the $76 Billion Debate in Medicare Advantage

The Art of Stillness: Mastering Eka Pada Sarvangasana for Body and Mind

• Integrative Oncology and Holistic Care

The Art of Stillness: Mastering Eka Pada Sarvangasana for Body and Mind

Ammar Sabilarrohman July 3, 2026

Yoga Journal’s archival series revisits the wisdom of the 1981 classics, exploring the profound physical and psychological...

Read More Read more about The Art of Stillness: Mastering Eka Pada Sarvangasana for Body and Mind

AI and Human Radiologists: A Synergistic Alliance Redefining Breast Cancer Screening

• Medical Research and Clinical Trials

AI and Human Radiologists: A Synergistic Alliance Redefining Breast Cancer Screening

Asep Darmawan July 3, 2026

Main Facts URBANA-CHAMPAIGN, IL – The future of breast cancer screening may not lie in the complete...

Read More Read more about AI and Human Radiologists: A Synergistic Alliance Redefining Breast Cancer Screening

Median Technologies Secures CE Marking for AI-Driven Lung Cancer Detection Software, eyonis LCS

• Treatment Innovations

Median Technologies Secures CE Marking for AI-Driven Lung Cancer Detection Software, eyonis LCS

Jia Lissa July 3, 2026

In a major milestone for diagnostic oncology and artificial intelligence in medicine, French medical technology firm Median...

Read More Read more about Median Technologies Secures CE Marking for AI-Driven Lung Cancer Detection Software, eyonis LCS

The Biotech Renaissance: Navigating a Selective and High-Stakes Funding Environment in 2026

• Treatment Innovations

The Biotech Renaissance: Navigating a Selective and High-Stakes Funding Environment in 2026

Iffa Jayyana July 3, 2026

After navigating a prolonged period of stagnant growth, the global biopharmaceutical sector is experiencing a palpable, albeit...

Read More Read more about The Biotech Renaissance: Navigating a Selective and High-Stakes Funding Environment in 2026

Beyond the Expiration Date: The Evolving Landscape of Metastatic Breast Cancer Advocacy

• Patient Advocacy and Support

Beyond the Expiration Date: The Evolving Landscape of Metastatic Breast Cancer Advocacy

Asep Darmawan July 3, 2026

By [Your Publication Name] Staff Published: October 24, 2025 The narrative surrounding breast cancer is frequently dominated...

Read More Read more about Beyond the Expiration Date: The Evolving Landscape of Metastatic Breast Cancer Advocacy